U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062523) titled 'Analyse of Inflammatory Activity of Sjogren's Syndrome on 68Ga-FAPI PET-CT' on June 28, 2024.
Brief Summary: Sjogren's syndrome (SS) is a chronic autoimmune disease primarily affecting the salivary and lacrimal glands, leading to symptoms of dryness. Assessing the inflammatory activity is crucial for guiding treatment. Fibroblast activation protein (FAPI) PET is an emerging imaging technique increasingly used for evaluating various inflammations and tumors. Thus this prospective study is going to investigate the uptake characteristics of FAPI PET in Sjogren's syndrome and evaluate its potential in assessing inflammatory activity to ...